eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2022
vol. 47
 
Share:
Share:
abstract:
Letter to the Editor

Chronic mucocutaneous candidiasis, pancytopenia, and systemic mycosis in a patient with STAT1 gene mutation ineffectively treated with ruxolitinib

Stanisława Bazan-Socha
1
,
Ada Gradzikiewicz
1
,
Magdalena Celińska-Lowenhoff
1
,
Aleksandra Matyja-Bednarczyk
1
,
Anna Maciołek
2
,
Katarzyna Bąbol-Pokora
3

  1. Department of Internal Medicine, Jagiellonian University Medical College, Cracow, Poland
  2. Department of Metabolic Diseases and Diabetology, Jagiellonian University Medical College, Cracow, Poland
  3. Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland
Cent Eur J Immunol 2022; 47 (1): 92-94
Online publish date: 2022/05/10
View full text Get citation
 
PlumX metrics:
We present a case of a white adult female patient who suffered from chronic mucocutaneous candidiasis (CMC) since infancy. Her parents were not consanguineous, and neither of them nor any other family member, including an older sister, suffered from similar symptoms. The patient often received prolonged courses of antifungal antibiotics, but the regimens were always insufficiently effective. The differential diagnosis included atopic dermatitis or acrodermatitis enteropathica, a rare, usually genetic disorder of zinc metabolism characterized by pustular dermatitis, diarrhea, and nail dystrophy. At the age of 18, the patient was diagnosed with type 1 diabetes mellitus. Five years later, human immunoglobulin substitution was started due to immunoglobulin (Ig) G2 and IgG4 mild deficiency.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.